Europe
For Use with SynchroMed(TM) II Intrathecal Drug Delivery System, the Control WorkflowAims to Effectively Address Chronic Pain Without the Use of Oral Opioids
Locate Bio Limited today announces that it has changed its name from Locate Therapeutics Limited and received a new direct investment of £0.5 million from Mercia Technologies PLC (AIM: MERC) (“Mercia”).
CYROLITE® high performance acrylic-based polymers meet the highest quality and safety requirements for medical and diagnostic applications
DNAe was named ‘Best Diagnostic Medtech Company’ at the 2018 OBN Awards.
It has been six years since Johnson & Johnson first launched its JLABS incubators for the life science industry with a vision of providing assistance to startups that could potentially bring about a new paradigm of care for patients.
This week will have moderate activity by the U.S. Food and Drug Administration (FDA). Although they jumped the gun on Regeneron and Sanofi’s cancer drug, there are still plenty of other decisions being made this week. Here’s a look.
Execs at Novo Nordisk, AbbVie, and more made moves this week. Here’s a roundup of those changes.
Mymetics Corporation announced today that Mymetics BV, the Dutch subsidiary of Mymetics Corporation, has entered into a research collaboration project with eTheRNA immunotherapies NV, a clinical stage biotech company developing novel mRNA cancer immunotherapies.
BC Platforms today announced it is launching its world leading genomics platform for HUS, the Hospital District of Helsinki and Uusimaa and the largest Healthcare service provider in the whole Nordics region.
The shareholders of Immunicum AB (publ) (the “Company”), reg. no 556629-1786, hereby summon to Extraordinary General Meeting on Thursday, 8 November 2018, at 14:30 p.m. at United Spaces, Östra Hamngatan 16, SE-411 Gothenburg, conference room Arenan. Registration for the meeting will commence at 14:00 p.m.
PRESS RELEASES